In this presentation, Robert Lustig, MD, Professor of Clinical Radiation Oncology at Penn Medicine, considers the application of proton therapy (PT) to the treatment of low-grade gliomas. Dr. Lustig’s discussion includes an explanation of the comparative advantages of PT vs intensity-modulated radiation therapy (IMRT) for irradiation of the brain, an introduction to the Roberts Proton Therapy Center, and a discussion of PT treatment for low-grade gliomas, including a symptom-assessment study performed at Penn that found generally milder and briefer episodes of nausea, headache, fatigue and anorexia for PT.
- Clinical Briefing: Enrolling Clinical Trials: Proton Beam Radiation for WHO Grade IIII Meningiomas and Hemangiopericytomas
- Clinical Study: A phase II study to collect longitudinal data on fatigue and quality of life after proton therapy and gather toxicity data. Local control rates will also be evaluated.
- Dr. Lustig’s Profile